Davita Healthcare Partners Inc (DVA)

$150.72 -2.34 (-1.53%)
Market Cap 10.07B
Revenue (ttm) 13.64B
Net Income (ttm) 746.80M
EPS (ttm) N/A
PE Ratio 13.88
Forward PE 10.81
Profit Margin 5.47%
Debt to Equity Ratio -28.02
Volume 1,271,400
Avg Vol 1,142,228
Day's Range N/A - N/A
Shares Out 66.80M
Stochastic %K 42%
Beta 0.94
Analysts Sell
Price Target $151.00

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administ...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720 631 2100
Address:
2000 16th Street, Denver, United States
Noname2022
Noname2022 Mar. 14 at 6:50 PM
$CRMD $AKBA $FMS $DVA GovTrack currently shows about a 3% chance of enactment for the bill. Worth noting: Rep. Mike Kelly joined as a cosponsor on Jan 30 and sits on the House Ways & Means Health Subcommittee, the committee responsible for Medicare dialysis policy and the upcoming kidney hearing.
5 · Reply
Noname2022
Noname2022 Mar. 12 at 10:53 PM
$CRMD $AKBA $DVA $FMS
0 · Reply
SweStonk
SweStonk Mar. 6 at 9:47 PM
$CRMD I have never been more certain about the success of a drug like defencath. Within 10 years we will be SoC and everyone will use defencath. Less infections = cheaper costs Less infections = lower deaths RWE 70%, it is huge and TDAPA dip uncertainty wont last long. Dont let the bears fool you. BUY when others are fearful. Joe would NEVER announce share repurchase this early if he wasnt confident about defencaths future. This is a FUCKING gold mine at this price! $DVA $XBI $IBB
2 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 6:48 PM
$DVA up 11.5% in 6 months — is it poised for more growth? 🚀 DaVita's solid Q4 results and projected overseas growth are driving optimism, with a Zacks Rank #2 (Buy). But keep an eye on its dependence on commercial payers. Discover the full investment picture here 👉 https://www.zacks.com/stock/news/2880351/heres-why-you-should-add-davita-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2880351-body-36468&ADID=SYND_STOCKTWITS_TWEET_2_2880351_BODY_36468
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 5:48 PM
$DVA is back on investors’ radar after strong Q4 results — but there’s a catch. The company is drawing attention on solid quarterly performance and steady global expansion, though its heavy reliance on commercial insurers still raises a key risk to watch. ⚠️ See why the stock is getting fresh attention 👉 https://www.zacks.com/stock/news/2880351/heres-why-you-should-add-davita-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2880351-teaser-36410&ADID=SYND_STOCKTWITS_TWEET_2_2880351_TEASER_36410
0 · Reply
Noname2022
Noname2022 Mar. 5 at 2:32 PM
$AKBA $CRMD $DVA $FMS
0 · Reply
Noname2022
Noname2022 Mar. 5 at 1:14 AM
$AKBA $CRMD $DVA $FMS
1 · Reply
Noname2022
Noname2022 Mar. 4 at 7:55 PM
$CRMD $AKBA $FMS $DVA
2 · Reply
Noname2022
Noname2022 Mar. 2 at 11:06 PM
$AKBA $DVA $FMS
0 · Reply
Noname2022
Noname2022 Mar. 2 at 7:16 PM
$AKBA $CRMD $DVA $FMS Not TDAPA related, still bipartisan kidney related legislation advancing out of committee to the floor
0 · Reply
Latest News on DVA
DaVita Inc. (DVA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 2:07 PM EST - 13 days ago

DaVita Inc. (DVA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 24, 2026, 2:00 PM EST - 19 days ago

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

20 stocks of companies that delivered a double dose of growth this earnings season

Feb 11, 2026, 10:45 AM EST - 4 weeks ago

20 stocks of companies that delivered a double dose of growth this earnings season

APH BA CAH FICO GLW GOOG GOOGL

DaVita Stock Rallies On Profit Beat, Confident 2026 View

Feb 3, 2026, 12:25 PM EST - 5 weeks ago

DaVita Stock Rallies On Profit Beat, Confident 2026 View

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

Feb 3, 2026, 11:00 AM EST - 5 weeks ago

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

PEP TER

DaVita: Some Success Is Possible, But Volatility Is Still Heavy

Feb 3, 2026, 10:30 AM EST - 5 weeks ago

DaVita: Some Success Is Possible, But Volatility Is Still Heavy

DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript

Feb 2, 2026, 7:30 PM EST - 5 weeks ago

DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Feb 2, 2026, 5:06 PM EST - 5 weeks ago

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

DaVita Inc. 4th Quarter 2025 Results

Feb 2, 2026, 4:05 PM EST - 5 weeks ago

DaVita Inc. 4th Quarter 2025 Results

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

Jan 21, 2026, 10:00 AM EST - 7 weeks ago

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

DaVita Names New Leaders to Accelerate Care Transformation

Dec 11, 2025, 8:00 AM EST - 3 months ago

DaVita Names New Leaders to Accelerate Care Transformation

DaVita: More Volatile But Better Upside Than Fresenius

Dec 3, 2025, 9:30 AM EST - 3 months ago

DaVita: More Volatile But Better Upside Than Fresenius

DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 17, 2025, 1:57 PM EST - 4 months ago

DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 14, 2025, 4:16 PM EST - 4 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Nov 4, 2025, 8:00 AM EST - 4 months ago

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:46 PM EDT - 4 months ago

DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript

DaVita misses quarterly profit estimates on rising costs, lower volumes

Oct 29, 2025, 5:32 PM EDT - 4 months ago

DaVita misses quarterly profit estimates on rising costs, lower volumes

DaVita Inc. 3rd Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 4 months ago

DaVita Inc. 3rd Quarter 2025 Results

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

Oct 20, 2025, 8:00 AM EDT - 5 months ago

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Oct 13, 2025, 2:00 PM EDT - 5 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Aug 27, 2025, 8:00 AM EDT - 7 months ago

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 21, 2025, 5:59 PM EDT - 7 months ago

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

DaVita: Aggressive Buybacks Despite Rising Cost Of Debt

Aug 20, 2025, 9:36 AM EDT - 7 months ago

DaVita: Aggressive Buybacks Despite Rising Cost Of Debt

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:02 PM EDT - 7 months ago

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 5:15 PM EDT - 7 months ago

DaVita beats quarterly profit on steady demand for dialysis services

DaVita Inc. 2nd Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 7 months ago

DaVita Inc. 2nd Quarter 2025 Results

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jul 17, 2025, 5:37 PM EDT - 8 months ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

Jun 2, 2025, 12:15 PM EDT - 10 months ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 30, 2025, 2:35 PM EDT - 10 months ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

DaVita: International Expansion And Buybacks Will Boost Returns

May 27, 2025, 11:30 AM EDT - 10 months ago

DaVita: International Expansion And Buybacks Will Boost Returns

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 4:42 PM EDT - 10 months ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 9:05 AM EDT - 10 months ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 10 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:41 PM EDT - 10 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 5:37 PM EDT - 10 months ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 10 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 10 months ago

DaVita Inc. 1st Quarter 2025 Results

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 11 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 11 months ago

DaVita Says Ransomware Attack Affecting Some Operations

Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 11 months ago

Dialysis firm DaVita hit by ransomware attack

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 1 year ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Mar 6, 2025, 10:00 AM EST - 1 year ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 27, 2025, 9:00 AM EST - 1 year ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 1 year ago

Berkshire Hathaway sells another 750,000 DaVita shares

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 1:01 PM EST - 1 year ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 14, 2025, 8:16 AM EST - 1 year ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:19 PM EST - 1 year ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 1 year ago

Berkshire sells some DaVita shares, cuts stake to 45%

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 1 year ago

DaVita forecasts 2025 profit below estimates, shares plummet

DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 1 year ago

DaVita Inc. 4th Quarter 2024 Results

Noname2022
Noname2022 Mar. 14 at 6:50 PM
$CRMD $AKBA $FMS $DVA GovTrack currently shows about a 3% chance of enactment for the bill. Worth noting: Rep. Mike Kelly joined as a cosponsor on Jan 30 and sits on the House Ways & Means Health Subcommittee, the committee responsible for Medicare dialysis policy and the upcoming kidney hearing.
5 · Reply
Noname2022
Noname2022 Mar. 12 at 10:53 PM
$CRMD $AKBA $DVA $FMS
0 · Reply
SweStonk
SweStonk Mar. 6 at 9:47 PM
$CRMD I have never been more certain about the success of a drug like defencath. Within 10 years we will be SoC and everyone will use defencath. Less infections = cheaper costs Less infections = lower deaths RWE 70%, it is huge and TDAPA dip uncertainty wont last long. Dont let the bears fool you. BUY when others are fearful. Joe would NEVER announce share repurchase this early if he wasnt confident about defencaths future. This is a FUCKING gold mine at this price! $DVA $XBI $IBB
2 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 6:48 PM
$DVA up 11.5% in 6 months — is it poised for more growth? 🚀 DaVita's solid Q4 results and projected overseas growth are driving optimism, with a Zacks Rank #2 (Buy). But keep an eye on its dependence on commercial payers. Discover the full investment picture here 👉 https://www.zacks.com/stock/news/2880351/heres-why-you-should-add-davita-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2880351-body-36468&ADID=SYND_STOCKTWITS_TWEET_2_2880351_BODY_36468
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 5:48 PM
$DVA is back on investors’ radar after strong Q4 results — but there’s a catch. The company is drawing attention on solid quarterly performance and steady global expansion, though its heavy reliance on commercial insurers still raises a key risk to watch. ⚠️ See why the stock is getting fresh attention 👉 https://www.zacks.com/stock/news/2880351/heres-why-you-should-add-davita-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2880351-teaser-36410&ADID=SYND_STOCKTWITS_TWEET_2_2880351_TEASER_36410
0 · Reply
Noname2022
Noname2022 Mar. 5 at 2:32 PM
$AKBA $CRMD $DVA $FMS
0 · Reply
Noname2022
Noname2022 Mar. 5 at 1:14 AM
$AKBA $CRMD $DVA $FMS
1 · Reply
Noname2022
Noname2022 Mar. 4 at 7:55 PM
$CRMD $AKBA $FMS $DVA
2 · Reply
Noname2022
Noname2022 Mar. 2 at 11:06 PM
$AKBA $DVA $FMS
0 · Reply
Noname2022
Noname2022 Mar. 2 at 7:16 PM
$AKBA $CRMD $DVA $FMS Not TDAPA related, still bipartisan kidney related legislation advancing out of committee to the floor
0 · Reply
Noname2022
Noname2022 Feb. 27 at 10:23 PM
$CRMD $AKBA $DVA $FMS a kidney bill that made it out of committee https://www.kidneyfund.org/article/american-kidney-fund-applauds-bipartisan-committee-approval-living-donor-protection-act
0 · Reply
Noname2022
Noname2022 Feb. 26 at 12:57 AM
$AKBA $DVA Vafseo available “village wide” since 11/10/2025 Q3 Rev: $14M Q4 Rev: $5-6M Can’t wait for all the excuses tomorrow… https://fintool.com/app/research/companies/AKBA/documents/transcripts/q3-2025
1 · Reply
Noname2022
Noname2022 Feb. 24 at 11:01 PM
$CRMD $AKBA $FMS $DVA
0 · Reply
Noname2022
Noname2022 Feb. 24 at 1:09 PM
$CRMD $AKBA $FMS $DVA https://www.congress.gov/bill/119th-congress/house-bill/6214/cosponsors
0 · Reply
TradeTracs
TradeTracs Feb. 23 at 5:59 AM
$DVA momentum based earnings flag riding 5ema daily within inside week
0 · Reply
Noname2022
Noname2022 Feb. 22 at 9:05 PM
$AKBA $DVA Anything less than 20% of Davita prescribers writing for the 20% of ESA hypo responders with 1st 30 days is a failure imho… widely available at Davita since Nov. 2025; wheres the Q4 LDO revenue?! https://ir.akebia.com/static-files/609bf97a-353c-47cd-aa61-693c9d06d337
1 · Reply
Noname2022
Noname2022 Feb. 18 at 12:10 PM
$AKBA $DVA $FMS
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 11:24 AM
$DVA Share Price: $148.97 Contract Selected: Jul 17, 2026 $150 Calls Buy Zone: $11.98 – $14.80 Target Zone: $20.10 – $24.57 Potential Upside: 58% ROI Time to Expiration: 150 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BitcoinWizard2009
BitcoinWizard2009 Feb. 16 at 3:50 AM
$BTC.X $DJT $DVA $MSTR Been waiting to see this 🧌 🤡 pop up again so I could block.
0 · Reply
whatascam
whatascam Feb. 16 at 3:49 AM
$DJT $BTC.X $MSTR $DVA You can always dilute… that can get you a couple more decades out of it.
0 · Reply
Fkubini2442
Fkubini2442 Feb. 16 at 3:42 AM
$BTC.X $DJT $DVA $MSTR
0 · Reply
BitcoinWizard2009
BitcoinWizard2009 Feb. 16 at 3:33 AM
$BTC.X $DJT $DVA $MSTR Makes a lot of sense, this 🤡 @HydrogenH2 is a TDS Wacko hates Tesla hates Bitcoin hates ICE wants America last and gets programmed to all the usually leftist causes as they come. A real NPC 🤖 I like when these types expose themselves, instant block.
1 · Reply